Resources:

Find resources by:

Sort by:

Date Resource A-Z Random

Resources from the last:

Box size:

Filer text box:

Topic familiarity:

Grid Layout:

Collections that use this topic:

Collection topics:

Adrenal Bone Cardiovascular Diabetes Endocrine-Disrupting Chemicals Endocrine-Related Cancer Metabolism Neuroendocrinology Obesity Reproduction Steroid and Steroidogenesis Thyroid

Diabetes Glucagon

Islets Insulin BetaCells Pancreas Glucose Hyperglycemia Hypoglycemia Insulinoma Glucagon IGF Type 1 Type 2

Resource not read: Query News

Resource not read: Query Programmes

Resource not read: Query You and Your Hormones

Prolonged acidosis in SGLT2i-induced euglycaemic diabetic ketoacidosis

How do I ... develop new diabetes drugs by studying natural peptide hormones in patients?

SEX-BASED IMPACT OF PANCREATIC ISLET STRESSORS IN GluCreERT2/Rosa26-eYFP MICE

GENETIC SYNDROMES LINKED TO INSULINOMA AND GLUCAGONOMA

SEX-SPECIFIC ISLET HORMONE RELEASE BY GHSR1A ANTAGONIST LEAP2

GLP-1 receptor activation and cancer cell chemosensitivity

PRECONCEPTION TREATMENT WITH METFORMIN OR EXENATIDE IN PCOS

GLP-1R/NPY2R AND REPRODUCTIVE FUNCTION IN MICE FED A HIGH-FAT DIET

Mechanisms of β cell dedifferentiation in diabetes

A Big Bang in Birmingham! Time for endocrine inspiration

A NEW ERA IN OBESITY MANAGEMENT

OBESITY AND TYPE 2 DIABETES: TIME TO PUT AWAY THE KNIVES?

FAQs (fat accumulation and quality) in non-alcoholic steatohepatitis

Towards self-management in type 1 diabetes

POLYCYSTIC OVARY SYNDROME: THE HUNT FOR NEW THERAPIES

STRESS, TRAUMA AND LATE EFFECTS OF BRAIN TUMOURS

BONE HEALTH AND BARIATRIC SURGERY: SHRINKING BONES?

UNDERSTANDING EARLY-ONSET TYPE 2 DIABETES

24 hours in the life of a hormone: what time is the right time for a pituitary function test?

GDF15: SOMATIC DISTRESS, APPETITE AND AVERSION

SPECIALIST PHARMACISTS IN ENDOCRINOLOGY AN EVOLVING ROLE

Endogenous insulin: its role in the initiation, progression and management of diabetes

Endocrinologist 123 Web

The Endocrinologist Autumn 14 -website.pdf

Endocrinologist 144 Web

Endocrinologist 155 Final File For Online

Endocrinologist 134 Web Updated

Endocrinologist 146 Web

Endocrinologist 153 Web Version

Endocrinologist 154 Web Version

Endocrinologist 129 Web

The Endocrinologist 115 Web FINAL.pdf

Endocrinologist 145 Web

Endocrinologist 150 Web

Endocrinologist 152 Final For Web

The Endocrinologist 117 Web.pdf

Endocrinologist 126

Endocrinologist 128 Web Updated

Endocrinologist 142 Web (1)

Endocrinologist 142 Web

ScreenSummerEndoComplete.pdf

Endocrinologist 135 Web

Endocrinologist 141 Web

The accuracy of diagnosing adrenal insufficiency in children undergoing glucagon stimulation test (GST)

GLP-1 and glucagon depict complementary actions on visceral adipose tissue that could mediate metabolic shifts towards catabolism

Growth Hormone Response to Glucagon Stimulation Test in Transitional Age

Glucagon-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a double-blind randomized placebo-controlled study

Evaluation of copeptin levels during glucagon stimulation test in children with suspected growth hormone deficiency

Activation of GPR120 by lipid agonists modulates glucagon secretion in pancreatic islets and improves glucose tolerance in mice

The Relation Between Serum Glucose and Growth Hormone Concentrations During Standard Glucagon Test for GH Release in Short Stature Children

GLP-1RAs and glucagon can reshape adipose differentiation in vitro by activating the browning process

Comparative Study of Glucose Response to Intramuscular Glucagon in Pediatric Growth Hormone Deficiency and Idiopathic Short Stature: What is the risk of hypoglycemia?

The stimulatory effects of glucagon on cortisol and GH secretion occur independently from FGF-21

Novel glucagon receptor antagonist peptides improve glycaemic control and partially protect against streptozotocin induced diabetes in mice

Does the glucagon challenge test add to the utility of a 72 h fast for spontaneous hypoglycemia?

Association of glucagon-to-insulin ratio and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus

Comparison of 1 μg ACTH, 250 μg ACTH and glucagon tests for assessment of the hypothalamo-pituitaryadrenal axis in healthy subjects

Cell-cell contact enhances insulin secretion from pancreatic beta-cells but not glucagon secretion from alpha-cells

Comparative analysis of the methods for differential diagnosis of non-diabetic hypoglycemia (NDH): Beta-hydroxybutyrate and glucagon test

Evaluation of minutes related to the maximum levels and random basal levels of growth hormone during stimulation test with glucagon

Expression and Localisation of Insulin, Glucagon, Amylin, Pancreatic Polypeptide and PDX-1 in Pancreatic Tissue of Children with Congenital Hyperinsulinism

Glucagon Response to Hypoglycemia During Extended Oral Glucose Tolerance Test in Children with Cystic Fibrosis and Comparing with Healthy Peers

10.25 A phase 3 multicenter, open-label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia in children and adolescents with T1DM in the home or school setting

Project to develop BSPED UK standardised guidelines for sex hormone priming and glucagon stimulation testing (GST) in children and adolescents

Elimination of fall in glucose during glucagon stimulation test does not completely abolish an increase in growth hormone and cortisol concentrations

Glucagon like peptide-1 in congestive heart failure cases and type 2 diabetes mellitus cases

Comparison of the low dose synacthen and glucagon stimulation tests in the assessment of adrenal function in children with short stature

Pharmacogenomics and efficacy outcome of therapy with glucagon-like peptide-1 receptor agonists in type 2 diabetes

The use of overnight fasting copeptin and glucagon stimulated copeptin to diagnose arginine vasopressin deficiency in a tertiary centre

Bright and specific far-red labels for visualizing endogenous glucagon-like peptide-1 receptors

Copeptin concentrations increase during glucagon stimulation test: possible role of copeptin in assessment of anterior pituitary function

Removal of the dominantly secreting adrenal lateralized by bilateral adrenal venous sampling (BAVS) with glucagon stimulation significantly alleviated hypertension in patients with bilateral adrenal pheochromocytoma

An Ongoing Phase 2 Study of HM15136, a Novel Long-acting Glucagon Analogue, in Subjects with Congenital Hyperinsulinism (ACHIEVE, Outline Protocol)

Glucagon like peptide-1 in congestive heart failure cases and type 2 diabetes mellitus cases

10.17. Efficacy of glucagon-like peptide-1 and estrogen dual agonist in pancreatic islets protection and preclinical models of insulin-deficient diabetes

Effect of bariatric surgery on serum glucagon like peptide-1 concentration and metabolic parameters among obese type 2 diabetics

Comparison of GHRH + arginine vs glucagon test for the evaluation of growth hormone secretion status in a cohort of adults with Prader-Willi syndrome (PWS)

4.1. Accuracy of glucagon testing across transition in young adults with childhood-onset growth hormone deficiency

Glucagon-like peptide-1 stimulates insulin secretion and then somatostatin secretion in rat islets

Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and reninangiotensinaldosterone system in healthy men

Glucagon-like-1 Receptor imaging specifically localizes insulinomas in patients with Multiple Endocrine Neoplasia Type 1 (MEN-1)

Effects of glucagon-like peptide-1 receptor agonists on bone blow flow and architecture in diabetic mice

Liraglutide, a glucagon-like peptide-1 receptor agonist, improves bone mass and architecture in ovariectomised mice

Monitoring thyroid function in diabetic patients on treatment with glucagon-like peptide 1 analog

Glucagon-like peptide-1 responses following multiple meals in lean and obese subjects

Increased Glucagon-Like Peptide-1 Response to Oral Glucose in Prepubertal Obese Children

The comparison of combination test either with 1 μg acth test and glucagon test for the evaluation of hypothalamo-pituitary-adrenal axis in patients with pituitary disorders

Glucagon-like peptide-1 analogues: a new way to quit smoking? SKIP  a randomised controlled study

A comparison of glucagon stimulation and insulin tolerance test in young adults followed craniospinal irradiation

Could <sup>99m</sup>Tc labelled glucagon-like peptide 1 analogue scintigraphy be an answer for patients with persistent hypoglycaemia?

11.12. Patients with obesity caused by melanocortin-4 receptor mutations can be treated with a glucagon-like peptide-1 receptor agonist

Audit of pituitary dysfunction after traumatic brain injury: caution in interpretation of glucagon stimulation test in diagnosis of GH and ACTH deficiency.

Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide in polycystic ovary syndrome